PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTHERN TRUST CORP | 81,595 | $367,178 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 70,165 | $315,743 | 0.00% |
| Legal & General Group Plc | 962 | $4,329 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 242,294 | $1,090,323 | 0.00% |
| STATE STREET CORP | 183,809 | $827,141 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 138,493 | $623,218 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 20,000 | $90 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 4,000 | $18,000 | 0.00% |
| CITIGROUP INC | 3,841 | $17,285 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 85,793 | $386,069 | 0.00% |
| GOLDMAN SACHS GROUP INC | 23,788 | $107,046 | 0.00% |
| MORGAN STANLEY | 195,326 | $878,968 | 0.00% |
| AMALGAMATED BANK | 964 | $4 | 0.00% |
| BlackRock Inc. | 859,121 | $3,866,046 | 0.00% |
| Bank of New York Mellon Corp | 30,816 | $138,672 | 0.00% |
| Citadel Advisors | 500 | $2,250 | 0.00% |
| Citadel Advisors | 1,200 | $5,400 | 0.00% |
| Citadel Advisors | 36,869 | $165,911 | 0.00% |
| Daiwa Securities Group Inc. | 104 | $0 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q2 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.